List of Exhibits
Exhibit 1 Segmentation of Global Single-use Bioprocessing Market
Exhibit 2 Market Size Calculation Approach 2020
Exhibit 3 Impact of Increasing Strategic Acquisitions & Partnerships
Exhibit 4 Impact of New Product Launches
Exhibit 5 Areas of Interests in the New Product Development by Biotherapeutic Developers & CMOs
Exhibit 6 Impact of High Utilization of Single-use Bioprocessing for COVID-19 Vaccine Production
Exhibit 7 Long-term Effects of COVID-19 on Single-use Bioprocessing
Exhibit 8 Impact of Technological Advances Witnessed in SUB
Exhibit 9 Impact of Increasing Adoption of Single-use Technologies Over Multi-use Bioprocessing Platforms
Exhibit 10 Advantages of Single-use Bioprocessing
Exhibit 11 Comparison of Several Parameters for Single-use and Traditional Manufacturing Technology (%)
Exhibit 12 Usage of Single-use Bioprocessing by Developers and CMOs
Exhibit 13 Impact of Reduced Water Consumption and Lesser Environment Impact of Single-use Technologies
Exhibit 14 Comparison of Water and Energy Consumption by Single-use and Conventional Systems
Exhibit 15 Environmental Impact of Single-use and Traditional Biopharmaceutical Manufacturing Technology
Exhibit 16 Lifecycle Endpoint Impact of Single-use and Traditional Systems
Exhibit 17 Impact of Lower Risk of Cross Contamination and Lower Manufacturing Cost
Exhibit 18 Investment Cost Reduction Associated with Single-use Installation in Upstream Bioprocessing
Exhibit 19 Impact of High Uptake of Biopharmaceuticals & Biosimilars
Exhibit 20 Uptake of Biosimilars in Various Countries
Exhibit 21 Biologics Sales Worldwide (%)
Exhibit 22 Impact of Increasing Demand for Flexible Bioprocessing and Lesser Floor Space Requirements
Exhibit 23 Percentage of Space Reduction by Single-use Systems Compared with Traditional Systems
Exhibit 24 Impact of Leachables & Extractables with Single-use Bioprocessing
Exhibit 25 Concern of Leachables and Extractables by CMOs and Biotherapeutic Developers
Exhibit 26 Impact of High-Cost of Single-Use Bioprocessing
Exhibit 27 Percentage Restriction of SUS by CMOs and Biotherapeutic Developers
Exhibit 28 Reasons Obstructing the Usage of Single-use Bioprocessing
Exhibit 29 Impact of Challenges with Scalability, Product Compatibility and Compliance
Exhibit 30 Challenges Concerning Implementation of Single-Use Bioprocessing System
Exhibit 31 Impact of Regulatory Uncertainties Impacting the Adoption of Single-Use Bioprocessing
Exhibit 32 Global Single-use Bioprocessing Market 2020–2026 ($ million)
Exhibit 33 Global Single-use Bioprocessing Market by Geography
Exhibit 34 Global Single-use Bioprocessing Market by Product
Exhibit 35 Global Single-use Bioprocessing Market by Application
Exhibit 36 Global Single-use Bioprocessing Market by End-user
Exhibit 37 Global Single-use Bioprocessing Market by Method
Exhibit 38 Five Forces Analysis 2020
Exhibit 39 Incremental Growth by Product 2020 & 2026
Exhibit 40 Global Single-use Bioprocessing Market by Product
Exhibit 41 Global Single-use Bioprocessing Market by Product: Incremental Growth Comparison ($ million)
Exhibit 42 Global Single-use Bioprocessing Market by Product: Absolute Growth Comparison (%)
Exhibit 43 Global Single-use Bioprocessing Market by Single-use Bioprocessing Equipment 2020−2026 ($ million)
Exhibit 44 Global Single-use Bioprocessing Market by Simple & Peripheral Elements 2020-2026 ($ million)
Exhibit 45 Incremental Growth by Application 2020 & 2026
Exhibit 46 Global Single-use Bioprocessing Market by Application
Exhibit 47 Global Single-use Bioprocessing Market by Application: Incremental Growth Comparison ($ million)
Exhibit 48 Global Single-use Bioprocessing Market by Application: Absolute Growth Comparison (%)
Exhibit 49 Global Single-use Bioprocessing Market by Monoclonal Antibodies 2020–2026 ($ million)
Exhibit 50 Global Single-use Bioprocessing Market by Vaccines 2020–2026 ($ million)
Exhibit 51 Global Single-use Bioprocessing Market by Cell Therapies 2020–2026 ($ million)
Exhibit 52 Global Single-use Bioprocessing Market by Other Applications 2020−2026 ($ million)
Exhibit 53 Incremental Growth by End-User 2020 & 2026
Exhibit 54 Global Single-use Bioprocessing Market by End-user
Exhibit 55 Global Single-use Bioprocessing Market by End-user: Incremental Growth Comparison ($ million)
Exhibit 56 Global Single-use Bioprocessing Market by End-user: Absolute Growth Comparison (%)
Exhibit 57 Global Single-use Bioprocessing Market by Biopharmaceutical Manufacturers 2020−2026 ($ million)
Exhibit 58 Adoption of SUBs by CMOs and Biopharmaceutical Developers
Exhibit 59 Global Single-use Bioprocessing Market by CMOs 2020−2026 ($ million)
Exhibit 60 Global Single-use Bioprocessing Market by R&D Companies and Research Institutes 2020−2026 ($ million)
Exhibit 61 Incremental Growth by Method 2020 & 2026
Exhibit 62 Global Single-use Bioprocessing Market by Method
Exhibit 63 Global Single-use Bioprocessing Market by Method: Incremental Growth Comparison ($ million)
Exhibit 64 Global Single-use Bioprocessing Market by Method: Absolute Growth Comparison (%)
Exhibit 65 Global Single-use Bioprocessing Market by Filtration 2020−2026 ($ million)
Exhibit 66 Global Single-use Bioprocessing Market by Storage & Transport 2020−2026 ($ million)
Exhibit 67 Global Single-use Bioprocessing Market by Cell Culture 2020−2026 ($ million)
Exhibit 68 Global Single-use Bioprocessing Market by Mixing 2020−2026 ($ million)
Exhibit 69 Global Single-use Bioprocessing Market by Purification 2020−2026 ($ million)
Exhibit 70 Incremental Growth by Geography 2020 & 2026
Exhibit 71 Global Single-use Bioprocessing Market by Geography
Exhibit 72 Global Single-use Bioprocessing Market by Geography: Incremental Growth Comparison ($ million)
Exhibit 73 Global Single-use Bioprocessing Market by Geography: Absolute Growth Comparison (%)
Exhibit 74 Global Biopharmaceutical Manufacturing Facilities
Exhibit 75 Single-use Bioprocessing Market in North America 2020–2026 ($ million)
Exhibit 76 Incremental Growth by Product 2020 & 2026
Exhibit 77 Incremental Growth by Application 2020 & 2026
Exhibit 78 Incremental Growth by End-user 2020 & 2026
Exhibit 79 Incremental Growth in North America 2020 & 2026
Exhibit 80 Biopharmaceutical Research and Development Expenditure in US 2011 & 2019 ($ billion)
Exhibit 81 Comparison of Number of Biopharmaceutical Manufacturing Facilities in US, China, and India
Exhibit 82 Single-use Bioprocessing Market in US 2020–2026 ($ million)
Exhibit 83 Increasing Prevalence of Major Chronic Diseases in Canada
Exhibit 84 Cumulative Number of Biologics Approved by Health Canada 2015, 2017, & 2019
Exhibit 85 Single-use Bioprocessing Market in Canada 2020–2026 ($ million)
Exhibit 86 Comparison of Number of Approved Biosimilars in US and Europe
Exhibit 87 No. of Companies Involved in R&D Activities in the US, Europe & China
Exhibit 88 Single-use Bioprocessing Market in Europe 2020–2026 ($ million)
Exhibit 89 Incremental Growth by Product 2020 & 2026
Exhibit 90 Incremental Growth by Application 2020 & 2026
Exhibit 91 Incremental Growth by End-user 2020 & 2026
Exhibit 92 Incremental Growth in Europe 2020 & 2026
Exhibit 93 Prevalence of Chronic Diseases in Germany (%)
Exhibit 94 Global Biologics Delivered by Country (%)
Exhibit 95 Single-use Bioprocessing Market in Germany 2020−2026 ($ million)
Exhibit 96 Single-use Bioprocessing Market in France 2020−2026 ($ million)
Exhibit 97 Increasing Aging Demographics in Switzerland 2008, 2030, & 2045 (million)
Exhibit 98 Single-use Bioprocessing Market in Switzerland 2020−2026 ($ million)
Exhibit 99 Burden of Chronic Diseases in UK (%)
Exhibit 100 Single-use Bioprocessing Market in UK 2020−2026 ($ million)
Exhibit 101 Percentage Share of Chronic Diseases in Italy
Exhibit 102 High-research Intensive Biotechnological Industry in Italy
Exhibit 103 Single-use Bioprocessing Market in Italy 2020−2026 ($ million)
Exhibit 104 Prevalence of Chronic Diseases in the Spanish Population
Exhibit 105 Gross Domestic Research & Development Expenditure in Spain 2016 to 2019 (%)
Exhibit 106 Single-use Bioprocessing Market in Spain 2020−2026 ($ million)
Exhibit 107 Percentage of Deaths due to Chronic Diseases in South East Asia
Exhibit 108 Number of Biologics Patent Expiries and Sales at Risk from 2015–2030 ($ billion)
Exhibit 109 Single-use Bioprocessing Market in APAC 2020−2026 ($ million)
Exhibit 110 Incremental Growth by Product 2020 & 2026
Exhibit 111 Incremental Growth by Application 2020 & 2026
Exhibit 112 Incremental Growth by End-user 2020 & 2026
Exhibit 113 Incremental Growth in APAC 2020 & 2026
Exhibit 114 Prevalence Rates of Chronic Diseases in Rural Chinese Population
Exhibit 115 Research and Development Investment in China 2018 & 2019 ($ billion)
Exhibit 116 Single-use Bioprocessing Market in China 2020−2026 ($ million)
Exhibit 117 Prevalence of Chronic Diseases in Japan’s Elderly Population
Exhibit 118 Research & Development Expenditure in Japan by % Share GDP
Exhibit 119 Single-use Bioprocessing Market in Japan 2020−2026 ($ million)
Exhibit 120 Percentage Share of Aged 65 Years & Above Over Past Decade in Australia (%)
Exhibit 121 Single-use Bioprocessing Market in Australia 2020−2026 ($ million)
Exhibit 122 Percentage Prevalence of Disease Conditions in South Korea
Exhibit 123 Single-use Bioprocessing Market in South Korea 2020−2026 ($ million)
Exhibit 124 Percentage of Individuals Suffering from One or More Chronic Conditions by Age and Gender
Exhibit 125 Single-use Bioprocessing Market in India 2020−2026 ($ million)
Exhibit 126 Percentage of Aging Population in Latin America 2010−2050 (%)
Exhibit 127 Single-use Bioprocessing Market in Latin America 2020−2026 ($ million)
Exhibit 128 Incremental Growth by Product 2020 & 2026
Exhibit 129 Incremental Growth by Application 2020 & 2026
Exhibit 130 Incremental Growth by End-user 2020 & 2026
Exhibit 131 Incremental Growth in Latin America 2020 & 2026
Exhibit 132 Increasing Aging Population in Brazil from 2012 to 2050 (million)
Exhibit 133 Single-use Bioprocessing Market in Brazil 2020−2026 ($ million)
Exhibit 134 Estimated Increasing Trends in Breast and Lung Cancer in Mexicans
Exhibit 135 Single-use Bioprocessing Market in Mexico 2020−2026 ($ million)
Exhibit 136 Burden of Chronic NCDs in Colombia in Accordance with Age
Exhibit 137 Single-use Bioprocessing Market in Colombia 2020−2026 ($ million)
Exhibit 138 Growing Elderly Population from 2019 to 2100 in Argentina
Exhibit 139 Single-use Bioprocessing Market in Argentina 2020−2026 ($ million)
Exhibit 140 Number of Patient Population Suffering from Chronic Diseases in Middle East and Africa (million)
Exhibit 141 Single-use Bioprocessing Market in Middle East & Africa 2020−2026 ($ million)
Exhibit 142 Incremental Growth by Product 2020 & 2026
Exhibit 143 Incremental Growth by Application 2020 & 2026
Exhibit 144 Incremental Growth by End-user 2020 & 2026
Exhibit 145 Incremental Growth in Middle East & Africa 2020 & 2026
Exhibit 146 Prevalence of Chronic Kidney Disease Among Obese Population in Turkey
Exhibit 147 Single-use Bioprocessing Market in Turkey 2020−2026 ($ million)
Exhibit 148 Percentage Burden of Chronic Diseases in Saudi Arabia (%)
Exhibit 149 Single-use Bioprocessing Market in Saudi Arabia 2020−2026 ($ million)
Exhibit 150 Prevalence of Diabetes in UAE Based on Gender and Age
Exhibit 151 Single-use Bioprocessing Market in UAE 2020−2026 ($ million)
Exhibit 152 Prevalence of Various Chronic Diseases in South Africa
Exhibit 153 Single-use Bioprocessing Market in South Africa 2020−2026 ($ million)
Exhibit 154 Thermo Fisher Scientific Revenue 2017−2019 ($ million)
Exhibit 155 Thermo Fisher Scientific Revenue Share by Segments in FY2018 & 2019 ($ million)
Exhibit 156 Thermo Fisher Scientific Revenue Share by Region 2018 & 2019 ($ million)
Exhibit 157 Thermo Fisher Scientific R&D Investments from FY2017−2019 ($ million)
Exhibit 158 Sartorius Stedim Biotech Total Revenue from FY2017−2019 ($ million)
Exhibit 159 Sartorius Stedim Biotech R&D Investments 2017−2019 ($ million)
Exhibit 160 Sartorius Stedim Biotech Revenue Share by Regions 2018& 2019 ($ million)
Exhibit 161 Danaher Revenue FY2017−2019 ($ million)
Exhibit 162 Danaher Revenue Share by Segments in 2018 & 2019 ($ million)
Exhibit 163 Danaher Revenue Generated by Geographic Regions 2018 & 2019 ($ million)
Exhibit 164 Danaher R&D Investment 2017−2019 ($ million)
Exhibit 165 Merck KGaA Total Revenue Generated (FY2017−2019) ($ million)
Exhibit 166 Merck KGaA Revenue Generated by Segments in FY2018 & 2019 ($ million)
Exhibit 167 Merck KGaA Revenue Share by Regions 2018 & 2019 ($ million)
Exhibit 168 Merck KGaA R&D Investment FY2017−2019 ($ million)
Exhibit 169 Avantor Total Revenue FY2017−2019 ($ million)
Exhibit 170 Avantor Revenue Share by Segment based on Geography 2018& 2019 ($ million)
List Of Tables
Table 1 Key Caveats
Table 2 Currency Conversion 2013−2020
Table 3 Comparison of Single-use Bioprocessing & Traditional Stainless-steel Bioprocessing
Table 4 Key Strategic Acquisitions & Partnerships in Single-use Bioprocessing
Table 5 Companies Launching New Single-use Bioprocessing Products
Table 6 Difference between Single-use Manufacturing Facility & Conventional Stainless Manufacturing Facility
Table 7 Comparison of Single-use and Traditional Bioprocessing Systems
Table 8 Few Examples of Recent Approved Biologics and their Indications
Table 9 Facility Space Occupied by Stainless Steel and Single-use Systems (m2)
Table 10 Safety Concern of Final Product for Leachables/ Extractables
Table 11 Recent Advancements in Single-use Solutions
Table 12 Comparison of Single-use and Multi-use Bioreactors in terms of Process Time
Table 13 North America: Single-use Bioprocessing Market by Product 2020−2026 ($ million)
Table 14 North America: Single-use Bioprocessing Market by Product 2020−2026 (%)
Table 15 North America: Single-use Bioprocessing Market by Application 2020−2026 ($ million)
Table 16 North America: Single-use Bioprocessing Market by Application 2020−2026 (%)
Table 17 North America: Single-use Bioprocessing Market by End-user 2020−2026 ($ million)
Table 18 North America: Single-use Bioprocessing Market by End-user 2020−2026 (%)
Table 19 Europe: Single-use Bioprocessing Market by Product 2020−2026 ($ million)
Table 20 Europe: Single-use Bioprocessing Market by Product 2020−2026 (%)
Table 21 Europe: Single-use Bioprocessing Market by Application 2020−2026 ($ million)
Table 22 Europe: Single-use Bioprocessing Market by Application 2020−2026 (%)
Table 23 Europe: Single-use Bioprocessing Market by End-user 2020−2026 ($ million)
Table 24 Europe: Single-use Bioprocessing Market by End-user 2020−2026 (%)
Table 25 Currently Available Popular Biologics in APAC
Table 26 APAC: Single-use Bioprocessing Market by Product 2020−2026 ($ million)
Table 27 APAC: Single-use Bioprocessing Market by Product 2020−2026 (%)
Table 28 APAC: Single-use Bioprocessing Market by Application 2020−2026 ($ million)
Table 29 APAC: Single-use Bioprocessing Market by Application 2020−2026 (%)
Table 30 APAC: Single-use Bioprocessing Market by End-user 2020−2026 ($ million)
Table 31 APAC: Single-use Bioprocessing Market by End-user 2020−2026 (%)
Table 32 Few Examples of Recently Approved Biosimilars in Australia
Table 33 Patent Expirations of Few Original Biologics
Table 34 Few Examples of Approved Biosimilars in India and their Therapeutic Areas
Table 35 Some Available Biologics in Latin America
Table 36 Single-use Bioprocessing - New Product Launches
Table 37 Latin America: Single-use Bioprocessing Market by Product 2020−2026 ($ million)
Table 38 Latin America: Single-use Bioprocessing Market by Product 2020−2026 (%)
Table 39 Latin America: Single-use Bioprocessing Market by Application 2020−2026 ($ million)
Table 40 Latin America: Single-use Bioprocessing Market by Application 2020−2026 (%)
Table 41 Latin America: Single-use Bioprocessing Market by End-user 2020−2026 ($ million)
Table 42 Latin America: Single-use Bioprocessing Market by End-user 2020−2026 (%)
Table 43 Recently Launched Biosimilars in Middle East & Africa
Table 44 Middle East & Africa: Single-use Bioprocessing Market by Product 2020−2026 ($ million)
Table 45 Middle East & Africa: Single-use Bioprocessing Market by Product 2020−2026 (%)
Table 46 Middle East & Africa: Single-use Bioprocessing Market by Application 2020−2026 ($ million)
Table 47 Middle East & Africa: Single-use Bioprocessing Market by Application 2020−2026 (%)
Table 48 Middle East & Africa: Single-use Bioprocessing Market by End-user 2020−2026 ($ million)
Table 49 Middle East & Africa: Single-use Bioprocessing Market by End-user 2020−2026 (%)
Table 50 Global Single-use Bioprocessing Market: Vendors Ranking
Table 51 Thermo Fisher Scientific: Major Product Offerings
Table 52 Sartorius Stedim Biotech: Major Product Offerings
Table 53 Danaher: Major Product Offerings
Table 54 Merck KGaA: Major Product Offerings
Table 55 Avantor: Major Product Offerings
Table 56 Applikon Biotechnology: Major Product Offerings
Table 57 Eppendorf: Major Product Offerings
Table 58 CESCO Bioengineering: Major Product Offerings
Table 59 Corning: Major Product Offerings
Table 60 Rentschler Biopharma SE: Major Product Offerings
Table 61 Entegris: Major Product Offerings
Table 62 Meissner Filtration Product: Major Product Offerings
Table 63 Parker-Hannifin Corporation: Major Product Offerings
Table 64 PBS Biotech: Major Product Offerings
Table 65 Saint-Gobain: Major Product Offerings
Table 66 Sentinel Process Systems: Major Product Offerings
Table 67 ABEC: Major Product Offerings
Table 68 Adolf Kühner: Major Product Offerings
Table 69 Charter Medical: Major Product Offerings
Table 70 Holland Applied Technologies: Major Product Offerings
Table 71 Repligen: Major Product Offerings
Table 72 Solaris Biotech Solutions: Major Product offerings
Table 73 3M Company: Major Product Offerings
Table 74 Lonza: Major Product Offerings
Table 75 Pneumatic Scale Angelus: Major Product Offerings
Table 76 ARTeSYN Biosolutions: Major Product Offerings
Table 77 Wego Group: Major Product Offerings
Table 78 Distek: Major Product Offerings
Table 79 New Horizon Biotech: Major Product Offerings
Table 80 OmniBRx Biotechnologies: Major Product Offerings
Table 81 Yposkesi: Major Product Offerings
Table 82 Charge Point Technologies: Major Product Offerings
Table 83 High Purity New England: Major Product Offerings
Table 84 PendoTECH: Major Product Offerings
Table 85 AdvantaPure: Major Product Offerings
Table 86 TBL Performance Plastics: Major Product Offerings
Table 87 Cellon: Major Product Offerings
Table 88 Sysbiotech: Major Product Offerings
Table 89 Broadley-James: Major Product Offerings
Table 90 CerCell: Major Product Offerings
Table 91 PreSens-Precision Sensing: Major Product Offerings
Table 92 Emerson Electric: Major Product Offerings
Table 93 CPC: Major Product Offerings
Table 94 Watson-Marlow Fluid Technology Group: Major Product Offerings
Table 95 Foxx Life Sciences: Major Product Offerings
Table 96 DRM: Major Product Offerings
Table 97 W.L. Gore & Associates: Major Product Offerings
Table 98 Global Single-use Bioprocessing Market by Product 2020−2026 ($ million)
Table 99 Global Single-use Bioprocessing Market by Product 2020−2026 (%)
Table 100 Single-use Bioprocessing Equipment by Geography 2020−2026 ($ million)
Table 101 Single-use Bioprocessing Equipment by Geography 2020−2026 (%)
Table 102 Simple & Peripheral Elements by Geography 2020−2026 ($ million)
Table 103 Simple & Peripheral Elements by Geography 2020−2026 (%)
Table 104 Global Single-use Bioprocessing Market by Application 2020−2026 ($ million)
Table 105 Global Single-use Bioprocessing Market by Application 2020−2026 (%)
Table 106 Monoclonal Antibodies by Geography 2020−2026 ($ million)
Table 107 Monoclonal Antibodies by Geography 2020−2026 (%)
Table 108 Vaccines by Geography 2020−2026 ($ million)
Table 109 Vaccines by Geography 2020−2026 (%)
Table 110 Cell Therapies by Geography 2020−2026 ($ million)
Table 111 Cell Therapies by Geography 2020−2026 (%)
Table 112 Others by Geography 2020−2026 ($ million)
Table 113 Others by Geography 2020−2026 (%)
Table 114 Global Single-use Bioprocessing by End-user 2020−2026 ($ million)
Table 115 Global Single-use Bioprocessing by End-user 2020−2026 (%)
Table 116 Biopharmaceutical Manufacturers by Geography 2020−2026 ($ million)
Table 117 Biopharmaceutical Manufacturers by Geography 2020−2026 (%)
Table 118 CMOs by Geography 2020−2026 ($ million)
Table 119 CMOs by Geography 2020−2026 (%)
Table 120 R&D Companies and Research Institutes by Geography 2020−2026 ($ million)
Table 121 R&D Companies and Research Institutes by Geography 2020−2026 (%)
Table 122 Global Single-use Bioprocessing Market by Method 2020−2026 ($ million)
Table 123 Global Single-use Bioprocessing Market by Method 2020−2026 (%)
Table 124 Global Single-use Bioprocessing Market by Geography 2020−2026 ($ million)
Table 125 Global Single-use Bioprocessing Market by Geography 2020−2026 (%)
Table 126 North America by Product 2020−2026 ($ million)
Table 127 North America by Product 2020−2026 (%)
Table 128 Europe by Product 2020−2026 ($ million)
Table 129 Europe by Product 2020−2026 (%)
Table 130 APAC by Product 2020−2026 ($ million)
Table 131 APAC by Product 2020−2026 (%)
Table 132 Latin America by Product 2020−2026 ($ million)
Table 133 Latin America by Product 2020−2026 (%)
Table 134 Middle East & Africa by Product 2020−2026 ($ million)
Table 135 Middle East & Africa by Product 2020−2026 (%)
Table 136 North America by Application 2020−2026 ($ million)
Table 137 North America by Application 2020−2026 (%)
Table 138 Europe by Application 2020−2026 ($ million)
Table 139 Europe by Application 2020−2026 (%)
Table 140 APAC by Application 2020−2026 ($ million)
Table 141 APAC by Application 2020−2026 (%)
Table 142 Latin America by Application 2020−2026 ($ million)
Table 143 Latin America by Application 2020−2026 (%)
Table 144 Middle East & Africa by Application 2020−2026 ($ million)
Table 145 Middle East & Africa by Application 2020−2026 (%)
Table 146 North America by End-user 2020−2026 ($ million)
Table 147 North America by End-user 2020−2026 (%)
Table 148 Europe by End-user 2020−2026 ($ million)
Table 149 Europe by End-user 2020−2026 (%)
Table 150 APAC by End-user 2020−2026 ($ million)
Table 151 APAC by End-user 2020−2026 (%)
Table 152 Latin America by End-user 2020−2026 ($ million)
Table 153 Latin America by End-user 2020−2026 (%)
Table 154 Middle East & Africa by End-user 2020−2026 ($ million)
Table 155 Middle East & Africa by End-user 2020−2026 (%)